| abstract |
(57) [Summary]nThe present invention relates to the manufacture of a medicament for the treatment of disorders of the central and peripheral nervous system, in particular psychosis, pain, epilepsy, neurodegenerative diseases (Alzheimer's disease), stroke, head trauma, multiple sclerosis and the like. It relates to the use of α, α-diphenyl-1-piperidinebutanamide which inhibits glycine transport. The invention further comprises the novel compounds, their preparation and their pharmaceutical forms. |